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Introduction
Systemic Lupus Erythematosus (SLE) is a chronic auto-
immune disease that can involve any organ system, and
may lead to significant morbidity and even mortality.
Childhood-onset SLE (cSLE) is a rare disease with an
incidence of 0.3-0.9 per 100.000 children-years and a pre-
valence of 3.3-8.8 per 100.000 children.
Objectives
SLE is called the great mimicker, as the disease shares
characteristics with many other (autoimmune) diseases.
Especially when the classic malar rash is absent, diagnos-
ing SLE can be a challenge. Most patients who are diag-
nosed with juvenil SLE fulfill 4 or more of the American
College of Rheumatology (ACR) classification criteria for
SLE. The Systemic Lupus International Collaborating
Clinics (SLICC) have recently suggested a new set of cri-
teria for the classification of SLE. In recently study,
SLICC criteria performed better, was more sensitive
(p <0.001), and less specific (p = 0.016) than ACR criteria
in childhood.
Methods
JSLE patients (n = 83) from 2 different centers whose
diagnosis fulfilled four or more of the ACR criteria were
divided into two groups: those with at least one ACR
mucocutaneous criterion (ACR skin feature positive)
and those without (ACR skin feature negative) at diag-
nosis. The relative frequency of skin involvement was
described by the paediatric adaptation of SLICC.
Results
We studied 83 patients (83% female; 17% male) with
SLE from two regions of Turkey. The mean age at diag-
nosis was 13±2,95 years. The common criteria besides
ANA in ACR all patients were, respectively, haematolo-
gical [n = 55 (66%)], musculoskeletal [n = 45 (54%)],
and renal [n = 40 (48%)]. Fourty-five patients (54%) had
ACR-defined skin involvement with no significant
demographic differences compared with those without.
ACR skin feature positive patients showed greater major
organ involvement (haematological (68% vs 66%), renal
(51% vs 45%). At the time of diagnosis, median SLICC
score was 8 in ACR skin feature positive group while 6
in others. Fifty-eight per cent of ACR skin feature nega-
tive patients had skin involvement using SLICC (n=13),
which included maculopapular rash (76%), toxic epider-
mal necrosis (0.8%), bullous rash (19%), fotosensitive
rash (92%). The thirteen patients showed greater muscu-
loscaletal, haematological and renal involvement at diag-
nosis (P>0.05).
Conclusion
There are a number of other important mucocutaneous
manifestations commonly found in JSLE patients apart
from the four listed in the ACR criteria. These addi-
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